favipiravir
Health Ministry issues guidelines for rational use of medicines, tests for COVID-19 patients
The guidelines have stressed the use of wearing masks, physical distancing and hand hygiene
Russia approves first COVID-19 prescription drug for sale in pharmacies
R-Pharm’s announcement is another sign Russia is pushing hard to take a global lead in the race against the virus
Dr Reddy's launches COVID-19 drug Avigan (Favipiravir)
The launch is part of a global licensing agreement with Fujifilm Chemical that grants exclusive rights to manufacture and sell tablets
Hetero launches COVID-19 drug Favivir at Rs 59 per tablet
The product is available from July 29 at all retail medical outlets across the country and will be sold only on prescription, it said
Glenmark's Favipiravir shows positive results in Phase-3 COVID-19 trial
The results also demonstrated 40 per cent faster achievement of 'clinical cure' defined as the physician's assessment of normalization
FabiFlu more economical, effective treatment option for COVID-19: Glenmark tells DGCI
Glenmark also denied making any claims that “favipiravir alone” is effective in treatment of mild-to-moderate COVID-19 patients
Biophore gets DCGI nod to manufacture, export Favipiravir
CEO of Biophore said all starting materials for making favipiravir are either sourced locally or have been developed in-house for use
Glenmark Pharma cuts price of COVID-19 drug Favipiravir to Rs 75/tablet
Glenmark Pharmaceuticals had launched antiviral drug Favipiravir, under the brand name FabiFlu, last month at a price of Rs 103 per tablet
Japan struggles to find patients to enroll in clinical trials
Slowing new infections has led to a shortage of patients to enroll in trials, which are underway for more than a dozen potential vaccines
India's Glenmark to test potential covid19 drug combination
Glenmark is already conducting clinical trials in India of just favipiravir as a potential treatment for COVID-19